The A1 adenosine receptor (A1AR) agonist n6-cyclohexyladenosine (CHA, 1mM, Sigma Aldrich); the NMDA receptor antagonist (2R)-amino-5-phosphonopentanoate (AP5, 5 mM, Tocris); the AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione disodium salt hydrate (CNQX, 5 mM, Tocris); the peptidase inhibitor (2S,3R)-3-Amino-2-hydroxy-5-methylhexanoyl-Val-Val-Asp hydrochloride hydrate (Amastatin, 1 mM, Sigma Aldrich); Dynorphin A (100 μM, Tocris); and the κ-opioid receptor antagonist nor-Binaltorphimine dihydrochloride (nor-BNI, 27 μM intraparenchymal or 1.6 mM ICV, Tocris) were dissolved in isotonic saline.
6 cyano 7 nitroquinoxaline 2 3 dione disodium salt hydrate cnqx
Manufactured by Bio-Techne
6-cyano-7-nitroquinoxaline-2,3-dione disodium salt hydrate (CNQX) is a laboratory reagent used in research. It is a selective antagonist of AMPA and kainate receptors. CNQX is commonly used in the study of neurotransmission and neurological processes.
Automatically generated - may contain errors
Lab products found in correlation
Amastatin, by Merck Group (1 mentions)
N6 cyclohexyladenosine, by Merck Group (1 mentions)
Dynorphin a, by Bio-Techne (1 mentions)
Nor binaltorphimine dihydrochloride, by Bio-Techne (1 mentions)
Nor bni, by Bio-Techne (1 mentions)
Bicuculline methobromide, by Bio-Techne (1 mentions)
Complete freund s adjuvant cfa, by Merck Group (1 mentions)
2 protocols using 6 cyano 7 nitroquinoxaline 2 3 dione disodium salt hydrate cnqx
1
Pharmacological Modulation of Nociceptive Signaling
2
Immune Modulator and Neuronal Inhibitor Protocol
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Complete Freund’s adjuvant (CFA) and Capsaisin (Cap) were purchased from Sigma-Aldrich. DL-2-Amino-5-phosphonovaleric acid lithium salt (APV), bicuculline methobromide (BIC), and 6-Cyano-7-nitro-quinoxaline-2, 3-dione disodium salt hydrate (CNQX) were purchased from Tocris.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!